Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions ...

Gene therapy is revolutionizing how they're treated, and the Fred Hutch Cancer Center in Seattle is at the center of it all. ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells. Current treatments often fail to achieve durable remission, underscoring the ...

The 54-year-old CEO of Sermo is running relentlessly in an effort to raise $1 million for stem cell transplant research.

Discover the inspiring stories of Axola May and Lee-Ann Scholtz, two young South Africans battling blood cancer. Learn how ...

Bubbly and full of zeal, the Pomona resident remains positive despite facing his second battle with the disease. He expressed ...

Congratulations to Emeline Boet (PhD Tamburini's group), winner of the poster session held at the CRTOH retreat on May 26-27, 2025 in the Post Doc Category.